-
公开(公告)号：US20210236600A1
公开(公告)日：2021-08-05
申请号：US17020279
申请日：2020-09-14
Applicant: Ferring B.V.
Inventor： Helen Ulrika Sjögren , Charlotte Hojer-Pedersen
Abstract: The present invention pertains in general to the field of the stabilization of gonadotropin formulations, in particular liquid formulations of gonadotropins. The stabilization is achieved by a particular combination of excipients, preferably arginine and methionine. In a preferred embodiment, the formulation does not comprise a buffer.
-
公开(公告)号：US20230372447A1
公开(公告)日：2023-11-23
申请号：US18138000
申请日：2023-04-21
Applicant: Ferring B.V.
Inventor： Helen Ulrika Sjögren , Charlott Hojer-Pedersen
CPC classification number: A61K38/24 , A61K9/0019 , A61K47/183 , A61K9/08 , A61P15/08 , A61K47/26 , A61K47/10
Abstract: The present invention pertains in general to the field of the stabilization of gonadotropin formulations, in particular liquid formulations of gonadotropins. The stabilization is achieved by a particular combination of excipients, preferably arginine and methionine. In a preferred embodiment, the formulation does not comprise a buffer.
-
公开(公告)号：US11666635B2
公开(公告)日：2023-06-06
申请号：US17020279
申请日：2020-09-14
Applicant: Ferring B.V.
Inventor： Helen Ulrika Sjögren , Charlotte Hojer-Pedersen
CPC classification number: A61K38/24 , A61K9/0019 , A61K9/08 , A61K47/10 , A61K47/183 , A61K47/26 , A61P15/08
Abstract: The present invention pertains in general to the field of the stabilization of gonadotropin formulations, in particular liquid formulations of gonadotropins. The stabilization is achieved by a particular combination of excipients, preferably arginine and methionine. In a preferred embodiment, the formulation does not comprise a buffer.
-
公开(公告)号：US10792334B2
公开(公告)日：2020-10-06
申请号：US16079428
申请日：2017-02-24
Applicant: Ferring B.V.
Inventor： Helen Ulrika Sjögren , Charlotte Højer-Pedersen
Abstract: The present invention pertains in general to the field of the stabilization of gonadotropin formulations, in particular liquid formulations of gonadotropins. The stabilization is achieved by a particular combination of excipients, preferably arginine and methionine. In a preferred embodiment, the formulation does not comprise a buffer.
-
公开(公告)号：US20190060409A1
公开(公告)日：2019-02-28
申请号：US16079428
申请日：2017-02-24
Applicant: Ferring B.V.
Inventor： Helen Ulrika Sjögren , Charlotte Højer-Pedersen
Abstract: The present invention pertains in general to the field of the stabilization of gonadotropin formulations, in particular liquid formulations of gonadotropins. The stabilization is achieved by a particular combination of excipients, preferably arginine and methionine. In a preferred embodiment, the formulation does not comprise a buffer.
